Xyzagen specializes in nonclinical small molecule LC-MS/MS bioanalysis. Xyzagen supports drug candidates from compound screening through preclinical development and can transfer its methods to GLP labs that its consultants have worked with or client’s preferred vendors. Our internal staff and consultants can work together to ensure successful transfer of a qualified method and as the program progresses in development and metabolites are discovered we can effectively evaluate and update bioanalytical methods and evaluate systemic exposure of new metabolites. Our scientists and consultants work with you to provide a personalized and comprehensive service to help keep your bioanalytical methods off of critical path; where they shouldn’t be.
